Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of dihydroisoindolo[2,1-<i>a</i>]quinolin-11-ones, their <i>in silico</i> ADMET properties and <i>in vitro</i> antitumor activities.

RSC advances·2022
Same author

Anticancer potential of new 3-nitroaryl-6-(N-methyl)piperazin-1,2,4-triazolo[3,4-a]phthalazines targeting voltage-gated K<sup>+</sup> channel: Copper-catalyzed one-pot synthesis from 4-chloro-1-phthalazinyl-arylhydrazones.

Bioorganic chemistry·2020
Same author

Anti-leishmanial effect of spiro dihydroquinoline-oxindoles on volume regulation decrease and sterol biosynthesis of Leishmania braziliensis.

Experimental parasitology·2019
Same author

Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel.

Chemical biology & drug design·2018
Same author

In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.

Acta tropica·2018
Same author

Cancer and the metastatic substrate.

Ecancermedicalscience·2017

Related Experiment Video

Updated: May 18, 2026

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

[Limbal deficiency syndrome].

Francisco Arvelo1, Felipe Sojol, Carlos Cotte

  • 1Centro de Biociencias, Fundación IDEA, Carretera Nacional Hoyo de la Puerta, Valle de Sartanejas, Baruta, Edo, Miranda, Venezuela. franarvelo@yahoo.com

Investigacion Clinica
|September 18, 2012
PubMed
Summary
This summary is machine-generated.

Corneal stem cell loss causes vision loss. Tissue engineering using limbal cell cultures offers a safer, more effective alternative to traditional corneal transplants for restoring vision.

More Related Videos

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
07:39

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model

Published on: August 4, 2023

Isolation and Identification of Limbal Niche Cells
10:11

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Related Experiment Videos

Last Updated: May 18, 2026

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
04:55

A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse

Published on: November 17, 2016

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
07:39

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model

Published on: August 4, 2023

Isolation and Identification of Limbal Niche Cells
10:11

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Area of Science:

  • Ophthalmology
  • Stem Cell Biology
  • Tissue Engineering

Context:

  • The cornea's epithelium renewal relies on limbal stem cells.
  • Dysfunction of these cells leads to vision impairment.
  • Current treatments include limbal transplants, which have limitations.

Purpose:

  • To review the significance of limbal stem cell deficiency.
  • To discuss current and emerging therapeutic strategies.
  • To highlight tissue engineering approaches for corneal regeneration.

Summary:

  • Corneal epithelial defects and vision loss result from limbal stem cell issues.
  • Traditional limbal transplantation is common but carries risks.
  • Tissue engineering, particularly using cultured limbal cells, presents advanced solutions.

Impact:

  • Tissue engineering offers safer, more efficient corneal regeneration.
  • Cultured limbal cell techniques reduce rejection and treatment time.
  • This approach promises improved outcomes for patients with corneal disease.